0001237899-14-000030.txt : 20140226 0001237899-14-000030.hdr.sgml : 20140226 20140226165744 ACCESSION NUMBER: 0001237899-14-000030 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140224 FILED AS OF DATE: 20140226 DATE AS OF CHANGE: 20140226 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER RD CITY: TARRYTOWN STATE: NY ZIP: 10591-6707 BUSINESS PHONE: 9143477000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOLDBERG MURRAY A CENTRAL INDEX KEY: 0001226435 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 14645331 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2014-02-24 0 0000872589 REGENERON PHARMACEUTICALS INC REGN 0001226435 GOLDBERG MURRAY A 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 SVP Administration & Asst Secr Common Stock 2014-02-24 4 M 0 6334.0 90.07 A 69436 D Common Stock 2014-02-24 4 F 0 1664.0 342.63 D 67772 D Common Stock 2014-02-24 4 F 0 2407.0 342.63 D 65365 D Common Stock 2014-02-24 4 M 0 20000.0 52.03 A 85365 D Common Stock 2014-02-24 4 F 0 3036.0 342.63 D 82329 D Common Stock 2014-02-24 4 F 0 8747.0 342.63 D 73582 D Common Stock 2014-02-24 4 M 0 3893.0 90.07 A 77475 D Common Stock 2014-02-24 4 F 0 1023.0 342.63 D 76452 D Common Stock 2014-02-24 4 F 0 1479.0 342.63 D 74973 D Common Stock 2014-02-25 4 S 0 275.0 336.89 D 74698 D Common Stock 2014-02-25 4 S 0 1962.0 337.4 D 72736 D Common Stock 2014-02-25 4 S 0 3934.0 338.37 D 68802 D Common Stock 2014-02-25 4 S 0 1300.0 339.2 D 67502 D Common Stock 2014-02-25 4 S 0 1200.0 340.43 D 66302 D Common Stock 2014-02-25 4 S 0 2100.0 341.46 D 64202 D Common Stock 2014-02-25 4 S 0 500.0 342.19 D 63702 D Common Stock 2014-02-25 4 S 0 200.0 344.47 D 63502 D Common Stock 2014-02-25 4 S 0 100.0 345.02 D 63402 D Common Stock 2014-02-25 4 S 0 300.0 346.73 D 63102 D Common Stock 5650 I By 401(k) Plan Common Stock 750 I by Spouse Non-Qualified Stock Option (right to buy) 52.03 2014-02-24 4 M 0 20000.0 0.0 D 2021-12-16 Common Stock 20000 18079 D Non-Qualified Stock Option (right to buy) 90.07 2014-02-24 4 M 0 6334.0 0.0 D 2012-01-31 2016-12-18 Common Stock 6334 0 D Non-Qualified Stock Option (right to buy) 90.07 2014-02-24 4 M 0 3893.0 0.0 D 2012-01-31 2017-12-17 Common Stock 3893 0 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Represents volume-weighted average price of sales of 275 shares of Company stock on February 25, 2014 at prices ranging from $336.88 to $336.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 25, 2014 at each separate price. Represents volume-weighted average price of sales of 1,962 shares of Company stock on February 25, 2014 at prices ranging from $337.00 to $337.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 25, 2014 at each separate price. Represents volume-weighted average price of sales of 3,934 shares of Company stock on February 25, 2014 at prices ranging from $338.00 to $338.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 25, 2014 at each separate price. Represents volume-weighted average price of sales of 1,300 shares of Company stock on February 25, 2014 at prices ranging from $339.00 to $339.73. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 25, 2014 at each separate price. Represents volume-weighted average price of sales of 1,200 shares of Company stock on February 25, 2014 at prices ranging from $340.15 to $340.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 25, 2014 at each separate price. Represents volume-weighted average price of sales of 2,100 shares of Company stock on February 25, 2014 at prices ranging from $341.05 to $341.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 25, 2014 at each separate price. Represents volume-weighted average price of sales of 500 shares of Company stock on February 25, 2014 at prices ranging from $342.00 to $342.50. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 25, 2014 at each separate price. Represents volume-weighted average price of sales of 200 shares of Company stock on February 25, 2014 at prices ranging from $344.07 to $344.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 25, 2014 at each separate price. Represents volume-weighted average price of sales of 300 shares of Company stock on February 25, 2014 at prices ranging from $346.58 to $346.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 25, 2014 at each separate price. The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant. /s/**Murray A. Goldberg 2014-02-26